Granted Patent B2

US 10,463,673 · App. 15/950,367 · Granted Nov 5, 2019

Abstract

Claims (9)

1. An injectable pharmaceutical dosage form consisting of:

30 mg of meloxicam, or a salt thereof, wherein the meloxicam is in the form of particles having an effective average particle size of less than about 200 nm;

polyvinylpyrrolidone;

sodium deoxycholate;

sucrose; and

water.

2. The dosage form of claim 1 , wherein the effective average particle size of the meloxicam particles, or a salt thereof, is less than about 150 nm.

3. The dosage form of claim 1 , wherein the effective average particle size of the meloxicam particles, or a salt thereof, is less than about 100 nm.

4. A method of administering meloxicam to a human in need thereof comprising intravenously or intramuscularly injecting the pharmaceutical dosage form of claim 1 into the human.

Assignments (17)